Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture.
Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

Pharmaceuticals

Contamination by human and veterinary pharmaceutical derivatives refers to the undesirable presence of drug residues in the environment, including water, soil, and living organisms. This contamination can occur at various stages, including production, consumption, and disposal of medications. Main sources include releases from pharmaceutical facilities, wastewater discharges containing drug residues, and uncontrolled use of veterinary drugs in agriculture. Pharmaceutical contamination raises environmental and health concerns, impacting ecosystems and posing risks of antibiotic-resistant bacteria emergence. Conventional wastewater treatment methods may not efficiently remove these compounds, contributing to their persistence. Efforts are underway to develop advanced treatment technologies and sustainable pharmaceutical waste management practices. Regulations aim to limit releases and promote environmental monitoring to assess the extent of contamination by pharmaceutical derivatives.

MAPROTILINE IMPURITY D CRS (25 MG)

MAPROTILINE IMPURITY D CRS (25 MG)

NA

DISCOVER
MEASLES VACCINE (LIVE) BRP (400 MG)

MEASLES VACCINE (LIVE) BRP (400 MG)

NA

DISCOVER
MEBENDAZOLE CRS (20 MG)

MEBENDAZOLE CRS (20 MG)

31431-39-7

DISCOVER
MECLOZINE DIHYDROCHLORIDE CRS(150 MG)

MECLOZINE DIHYDROCHLORIDE CRS(150 MG)

1104-22-9

DISCOVER
MEDRONIC ACID CRS (20 MG)

MEDRONIC ACID CRS (20 MG)

1984-15-2

DISCOVER
MEDROXYPROGESTERONE ACETATE CRS (70 MG)

MEDROXYPROGESTERONE ACETATE CRS (70 MG)

71-58-9

DISCOVER
MEFENAMIC ACID CRS (50 MG)

MEFENAMIC ACID CRS (50 MG)

61-68-7

DISCOVER
MEFLOQUINE HYDROCHLORIDE CRS (100 MG)

MEFLOQUINE HYDROCHLORIDE CRS (100 MG)

51773-92-3

DISCOVER
MENADIONE CRS (100 MG)

MENADIONE CRS (100 MG)

58-27-5

DISCOVER
MENTHOL CRS (100 MG)

MENTHOL CRS (100 MG)

89-78-1

DISCOVER
MEPIVACAINE HYDROCHLORIDE CRS(100 MG)

MEPIVACAINE HYDROCHLORIDE CRS(100 MG)

1722-62-9

DISCOVER
MEPIVACAINE IMPURITY B CRS (40 MG)

MEPIVACAINE IMPURITY B CRS (40 MG)

NA

DISCOVER